237 related articles for article (PubMed ID: 16018977)
1. 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern.
Hedlund PB; Huitron-Resendiz S; Henriksen SJ; Sutcliffe JG
Biol Psychiatry; 2005 Nov; 58(10):831-7. PubMed ID: 16018977
[TBL] [Abstract][Full Text] [Related]
2. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
3. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
[TBL] [Abstract][Full Text] [Related]
4. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
[TBL] [Abstract][Full Text] [Related]
5. The effects of photic and nonphotic stimuli in the 5-HT7 receptor knockout mouse.
Gardani M; Biello SM
Neuroscience; 2008 Mar; 152(1):245-53. PubMed ID: 18065150
[TBL] [Abstract][Full Text] [Related]
6. Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep.
Monti JM; Leopoldo M; Jantos H; Lagos P
Pharmacol Biochem Behav; 2012 Aug; 102(2):373-80. PubMed ID: 22659581
[TBL] [Abstract][Full Text] [Related]
7. Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.
Guscott M; Bristow LJ; Hadingham K; Rosahl TW; Beer MS; Stanton JA; Bromidge F; Owens AP; Huscroft I; Myers J; Rupniak NM; Patel S; Whiting PJ; Hutson PH; Fone KC; Biello SM; Kulagowski JJ; McAllister G
Neuropharmacology; 2005 Mar; 48(4):492-502. PubMed ID: 15755477
[TBL] [Abstract][Full Text] [Related]
8. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
Monti JM; Leopoldo M; Jantos H
Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
[TBL] [Abstract][Full Text] [Related]
9. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests.
Bourin M; Chenu F; Ripoll N; David DJ
Behav Brain Res; 2005 Nov; 164(2):266-9. PubMed ID: 16087251
[TBL] [Abstract][Full Text] [Related]
10. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; Shelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Sands S; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2012 Aug; 342(2):429-40. PubMed ID: 22570363
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
12. Spinal 5-HT7 receptors are critical for alternating activity during locomotion: in vitro neonatal and in vivo adult studies using 5-HT7 receptor knockout mice.
Liu J; Akay T; Hedlund PB; Pearson KG; Jordan LM
J Neurophysiol; 2009 Jul; 102(1):337-48. PubMed ID: 19458153
[TBL] [Abstract][Full Text] [Related]
13. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
Sarkisyan G; Roberts AJ; Hedlund PB
Behav Brain Res; 2010 May; 209(1):99-108. PubMed ID: 20097233
[TBL] [Abstract][Full Text] [Related]
14. Functional, molecular and pharmacological advances in 5-HT7 receptor research.
Hedlund PB; Sutcliffe JG
Trends Pharmacol Sci; 2004 Sep; 25(9):481-6. PubMed ID: 15559250
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test.
Duarte FS; Lach G; Martins PR; Romeiro GA; de Lima TC
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):368-74. PubMed ID: 17920179
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system.
Machado DG; Bettio LE; Cunha MP; Capra JC; Dalmarco JB; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):642-50. PubMed ID: 19286446
[TBL] [Abstract][Full Text] [Related]
17. Effect of various classes of antidepressants in behavioral paradigms of despair.
Kulkarni SK; Dhir A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1248-54. PubMed ID: 17570574
[TBL] [Abstract][Full Text] [Related]
18. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.
Cryan JF; Mombereau C; Vassout A
Neurosci Biobehav Rev; 2005; 29(4-5):571-625. PubMed ID: 15890404
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression.
Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
Neuropharmacology; 2008 Dec; 55(8):1355-63. PubMed ID: 18796307
[TBL] [Abstract][Full Text] [Related]
20. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Eur J Pharmacol; 2006 Dec; 553(1-3):185-90. PubMed ID: 17097082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]